Treatment with nasal corticosteroids: An update;Nasale glukokortikosteroid-therapie: Ein update

Allergologie

Volumn 34, Issue 6, 2011, Pages 307-318

  Klimek, L ^a,b   Schendzielorz, P ^a,b   Hogger P ^c  

^a Zentrum fur Rhinologie und Allergologie   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Allergic rhinitis; Nasal polyps; Systemic bioavailability; Topical corticosteroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUNISOLIDE; FLUOCORTINE BUTYLESTER; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MOMETASONE FUROATE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC RHINITIS; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME INHIBITION; PROTEIN EXPRESSION; REVIEW; SINUSITIS; T LYMPHOCYTE ACTIVATION;

EID: 79960100471     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/alp34307     Document Type: Review

References (104)

1. Allen A, Down G, Newland A, Reynard K, Rousell V, Salmon E, Scott R. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Clin Ther. 2007; 29: 1415-1420. (Pubitemid 47354209)
2. Andersson KE, Bende M. Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Laryngol. 1984; 93: 179-182. (Pubitemid 14134874)
3. Argenti D, Colligon I, Heald D, Ziemniak J. Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide. J Clin Pharmacol. 1994; 34: 854-858. (Pubitemid 24325014)
4. Auphan N, DiDonato JA, Rossette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science. 1995; 270: 286-291.
5. Bachert C. Wirksamkeit und Verträglichkeit von Fluticasonpropionat bei der Behandlung der allergischen Rhinitis. Allergologie. 1998; 21: 150-165. (Pubitemid 28299053)
6. Baker C, Altman LC. The effect of dexamethasone and cromolyn sodium on intercellular adhesion molecules-1 expression on human nasal epithelial cells. J Allergy Clin Immunol. 1992; 89 (Abstract): 212.
7. Balle VH, Pedersen U, Engby B. Allergic perennial and nonallergic vasomotor rhinitis treated with budesonide nasal spray. Rhinology. 1980; 18: 135-142. (Pubitemid 11238765)
8. Barnes PJ, Adock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993; 14: 436-441. (Pubitemid 23362373)
9. Baroody M, Shenaq D, DeTineo M, Wang JH, Naclerio RM. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009; 123: 1342-1348.
10. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli S, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988; 81: 580-589. (Pubitemid 18089940)
11. Baumgarten CR, Togias A, Naclerio RM, Norman PS, Lichtenstein LM, Proud D. Kininogens are generated following nasal challenge with allergen in allergic individuals but not in non-allergic individuals. J Clin Invest. 1985; 76: 191-197. (Pubitemid 15240436)
12. Bende M, Lindquist N, Pipkorn U. The effect of a topical steroid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy. 1983; 38: 461-464. (Pubitemid 13008702)
13. Bentley AM, Cumberworth V, Varney VA. Studies during the pollen season in understanding allergic rhinitis. In: Godard P, Bousquet J, Michel FB. Advances in allergology and clinical immunology. Carnforth: Taylor and Francis Ltd.; 1992. p. 457-464.
14. Beswick KB, Kenyon GS, Cherry JR. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis. Curr Med Res Opin. 1985; 9: 560-567. (Pubitemid 15066127)
15. Bousquet J, Chanal I, Alquie MC, Charpin D, Didier A, Gemouty J, Greillier P, Ickovic MH, Maria Y, Montone F et al. Prevention of pollen rhinitis. Comparison of fluticasone propionate aqueous nasal spray versus disodium cromoglycate nasal spray. Allergy. 1993; 48: 327-333.
16. Brogden RN, Heel RC, Speight TM, Avery GS. Beclomethasone dipropionate. Areappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs. 1984; 28: 99-126.
17. Brown HM, Storey G, Jackson FA. Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five years experience. Br J Clin Pharmacol. 1977; 4: 283-286.
18. Bunnag C, Jareoncharsri P, Wong ECK. A double-blind comparison of nasal budesonide and oral astemizole for treatment of perennial rhinitis. Allergy. 1992; 47: 313-317.
19. Cheng CC, Baroody FM, Reed KC, Cook C, Rogenes P, Sengupta E, Togias AG, Naclerio RM. Effects of one year treatment with fluticasone propionate aqueous nasal spray (FPANS) and terfenadine (TER) on the nasal mucosa: I. Asafety study using electron and light microscopy. J Allergy Clin Immunol. 1997; 99: 2013-2013.
20. Clissold SP. Rhinitis. In: Barnes PJ, Mygind N. Budesonide: clinical experience in asthma and rhinitis. Manchester:AIDS press; 1988. p. 51-64.
21. Cockcroft DW, MacCormack DW, Newhouse MT, Hargreave FE. Beclomethasone dipropionate in allergic rhinitis. Can Med Assoc J. 1976; 115: 523-526.
22. Cox G, Ohtoshi T, Vancheri C, Denburg JA, Dolovich J, Gauldie J, Jordana M. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol. 1991; 4: 525-531.
23. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelialleucocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 1992; 89: 9991-9995.
24. Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005; 44: 61-98. (Pubitemid 40096038)
25. Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol. 2004; 60: 265-268. (Pubitemid 38916445)
26. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008; 63: 1292-1300.
27. Deuschl H, Drettner B. Nasal polyps treated with beclomethasone nasal aerosol. Rhinology. 1977; 15: 17-23. (Pubitemid 8101909)
28. Drettner B, Ebbesen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology. 1982; 20: 149-158.
29. Esmailpour N, Högger P, Rohdewald P. Binding kinetics of budesonide to the human glucocorticoid receptor. Eur J Pharm Sci. 1998; 6: 219-223. (Pubitemid 28473222)
30. Fattal-German M, Le Roy Ladurie F, Cerrina J, Lecerf F, Berrih-Aknin S. Expression and modulation of ICAM-1, TNF-alpha and RANTES in human alveolar macrophages from lung-transplant recipients in vitro. Transpl Immunol. 1998; 6: 183-192.
31. Findlay S, Huber F, Garcia J, Huang L. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy. 1992; 68: 228-232.
32. Frauenfelder FT, Myer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol. 1990; 109: 489-490.
33. Freeland H, Pipkorn U, Proud D, Naclerio RM, Lichtenstein LM, Peters SP. Leukotriene B4 as a mediator of early and late reactions to antigen in humans. The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989; 83: 634-642. (Pubitemid 19094613)
34. Frolund L. Efficacy of oral antihistamine, loratadine, as compared with nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol. 1992; 16: 527-531.
35. Hansen I, Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis. Acta Allerg (Kbh). 1974; 29: 281-287.
36. Harding SM. The human pharmacology of fluticasone propionate. Respir Med. 1990; 84: 25-29. (Pubitemid 20376961)
37. Harding SM, Heath S. Intranasal steroid aerosol in perennial rhinitis: comparison with an antihistamine compound. Clin Allergy. 1976; 6: 369-372.
38. Henriksen J, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Resp Dis. 1984; 130: 1014-1018. (Pubitemid 15186156)
39. Heppt W. Zytologie der Nasenschleimhaut. Berlin: Springer; 1995.
40. Högger P. Current concepts for optimizing the therapeutic index of glucocorticoid receptor ligands for oral and inhalative use: basic considerations and clinical reality. Curr Med Chem Anti-Inflamm Anti-Allergy Agents. 2003; 2: 395-408.
41. Högger P, Rohdewald P. Glucocorticoid receptors and fluticasone propionate. Rev Contemp Pharmacother. 1998; 9: 501-522. (Pubitemid 28482771)
42. Holopainen E, Grahne B, Malmberg H, Makinen J, Lindquist N. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis. 1982; 63: 221-228. (Pubitemid 13235860)
43. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous spray, astemizole, and the combination in the prophylactic treatment of ragweed-induced rhinoconjunctivitis. J Allergy Clin Immunol. 1989; 83: 627-633. (Pubitemid 19094612)
44. Kay AB. Asthma and inflammation. J Allergy Clin Immunol. 1991; 87: 893-910.
45. Knani N, Denburg JA, Evans S, Conway M, Jordana M, Dolovich J. Depletion of T lymphocytes in nasal polyps treated by topical steroid. J Allergy Clin Immunol. 1992; 89 (Abstract): 221.
46. Lindquist N, Balle V, Karma P, Karja J, Lindstrom D, Makinen J, Pukander J, Ruoppi P, Suonpaa J, Ostlund W et al. Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis - a 12 month multicenter study. Allergy. 1986; 41: 179-186. (Pubitemid 16052637)
47. Löfkvist T, Svensson G. Treatment of vasomotor rhinitis with beclomethasone dipropionate. Acta Allerg (Kbh). 1976; 31: 227-238.
48. Lund V. Fluticasone propionate - a new and effective treatment for both allergic and non-allergic perennial rhinitis. Allergy. 1999; 12 (Abstract): 347.
49. Mattoli S, Vittori E, Marini M. Corticosteroids downregulate the increased expression of GM-CSF, IL-6 and IL-8 in bronchial epithelium of asthmatic patients. J Allergy Clin Immunol. 1992; 89 (Abstract): 164.
50. Meltzer EO. Nasal cytological changes following pharmacological intervention. Allergy. 1995; 50: 15-20.
51. Munch E, Soborg M, Norreslet TT, Mygind N. A comparative study of dexchlorpheniramine maleate sustained tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy. 1983; 38: 517-524. (Pubitemid 13008709)
52. Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. BMJ. 1973; 4: 464-466.
53. Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head and Neck Surgery. 1998; 118: 648-654. (Pubitemid 28222208)
54. Mygind N, Lund V. Topical corticosteroid therapy of rhinitis. Clin Immunother. 1996; 5: 122-136.
55. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy. 1975; 5: 159-164.
56. Mygind N, Sorensen H, Pedersen CB. The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol.Alight- and scanning- electron-microscopic study of nasal polyps. Acta Otolaryngol (Stockh). 1978; 85: 437-443. (Pubitemid 8364378)
57. Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol. 1988; 82: 927-934. (Pubitemid 19000385)
58. Naclerio RM. Inflammation in allergic rhinitis. Res Clin Forums. 1992; 14: 49-55.
59. Naclerio RM. Intranasal steroids. In: Mygind N, Naclerio RM. Allergic and non-allergic rhinitis: clinical aspects. Copenhagen: WB Saunders; 1993, 114-122.
60. Naclerio RM, Proud D, Togias AG. Inflammatory mediators in late antigen-induced rhinitis.NEngl J Med. 1985; 313: 65-70.
61. Okuda M, Othsuka H. Basophilic cells in allergic nasal secretions. Arch Otorhinolaryngol. 1977; 214: 283-289. (Pubitemid 8044615)
62. Okuda M, Othsuka H, Sakaguchi K, Ohnishi M, Okubo K. Effect of anti-allergic treatment on nasal surface basophilic metachromatic cells in allergic rhinitis. Allergy Proc. 1989; 10: 23-26.
63. Pakes GE, Brogden RN, Heel RD, Speight TM, Avery GS. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis. Drugs. 1980; 19: 397-411. (Pubitemid 11236193)
64. Pederson S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy. 1997; 52: 1-34. (Pubitemid 27311095)
65. Pipkorn U. Budesonide and nasal allergen challenge testing in man. Allergy. 1982; 37: 129-134. (Pubitemid 12149458)
66. Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosa mast cells in allergic rhinitis. Allergy. 1983; 38: 125-129. (Pubitemid 13142107)
67. Pipkorn U, Norman PS, Middleton E Jr. Topical steroids. In: Mygind N, Weeke B. Allergic and vasomotor rhinitis: clinical aspects. Copenhagen: Munksgard; 1985, 165-179.
68. Pipkorn U, Proud D, Lichtenstein LM. Effects of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987; 80: 957-957.
69. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987; 316: 1506-1510. (Pubitemid 17076234)
70. Pipkorn U, Pukander J, Suonpaa J, Makinen J, Lindquist N. Long-term safety of budesonide nasal aerosol - a 5.5 year follow up study. Clin Allergy. 1988; 18: 253-259.
71. Pipkorn U, Rundcrantz H, Lindquist N. Budesonide - a new nasal steroid. Rhinology. 1980; 18: 171-175. (Pubitemid 11165555)
72. Proud D, Togias A, Naclerio RM, Crush S, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983; 72: 1678-1685. (Pubitemid 14229047)
73. Rachelefsky GS, Chervinsky P, Meltzer EO, Morris RM, Seltzer JM, Skoner DP, Storms WW. An evaluation of the effects of beclomethasone diproprionate on long-term growth in children. J Allergy Clin Immunol. 1998; 101: 236-240.
74. Rak S, Jacobson MR, Sudderick RM, Masuyama K et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy. 1994; 24: 930-939. (Pubitemid 24320325)
75. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma. J Allergy Clin Immunol. 1988; 81: 1042-1047.
76. Roca-Ferrer J, Mullol J, Lopez E, Xaubet A, Pujols L, Fernandez JC, Picado C. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophile survival and GM-CSF secretion. Eur Respir J. 1997; 10: 1489-1495. (Pubitemid 27311060)
77. Rudack C, Bachert C. Glucocorticosteroids rapidly inhibit allergen-induced expression of E-selectin in vitro in a mucosal model of allergic rhinitis. Allergy. 2000; 55: 363-368. (Pubitemid 30183055)
78. Sahay JN, Chatterjee SS, Engler C. Acomparative trial of flunisolide and beclomethasone dipropionate in the treatment of perennial allergic rhinitis. Clin Allergy. 1980; 10: 65-70. (Pubitemid 10207652)
79. Salomonsson P, Gottberg L, Heilborn H, Norrlind K, Pegelow KO. Efficacy of an oral antihistamine, astemizole, as compared to a nasal steroid spray in hay fever. Allergy. 1988; 43: 214-218.
80. Sarnstrand B, Jeppsson A, Malmstrom A, Brattsand R. Effect of glucocorticosteroids on hyaluronic acid synthesis in vitro in human fibroblast-like cells from lung and skin. In: Hogg JC, Ellul-Micalef R, Brattsand R. Glucocorticosteroids, inflammation and bronchial hyperreactivity. Amsterdam: Excerpta Medica; 1985. p. 157-166.
81. Scheinmann RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of I kappaBalpha in mediation of immunosuppression by glucocorticoids. Science. 1995; 270: 283-286.
82. Schenkel EJ, Skoner DP, Bronsky EA, Miller SD et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000; 105: 1-7.
83. Small P, Black M, Frenkiel S. Effect of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol. 1982; 70: 78-82.
84. Soderberg-Warner ML. Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr. 1984; 105: 840-841. (Pubitemid 15206725)
85. Sorensen H, Mygind N, Pedersen CB, Prytz S. Long term treatment of nasal polyps with beclomethasone dipropionate aerosol. III. Acta Otolaryngol (Stockh). 1976; 82: 260-262.
86. Szefler SJ. Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol. 2001; 108: 26-31.
87. Stellato C, Beck LA, Gorgone GAet al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol. 1995; 155: 410-418.
88. Storms W, Bronsky E, Findley S, Pearlman D, Rosenberg S, Shapiro G, Southern L, Tinkelman D, Weakley S, Welch M et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy. 1991; 66: 329-334.
89. Swiebert LA, Beck LA, Stellato C et al. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol. 1996; 97: 143-152. (Pubitemid 26049495)
90. Tarlo SM, Cockcroft DW, Dolovich J, Hargreave FE. Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol. 1977; 59: 232-236. (Pubitemid 8067165)
91. Thorsson L, Borga O, Edsbacker S. Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder. Br J Clin Pharmacol. 1999; 47: 619-624. (Pubitemid 29257659)
92. Toft A, Wihl JA, Toxman J, Mygind N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy. 1982; 12: 391-401. (Pubitemid 12049562)
93. Turkeltaub PC, Norman PS, Crepea S. Treatment of ragweed hay fever with an intranasal spray containing flunisolide: a new synthetic corticosteroid. J Allergy Clin Immunol. 1976; 58: 597-606.
94. Valotis A, Högger P. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res. 2007; 8: 54.
95. Valotis A, Neukam K, Elert O, Högger P. Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate. J Pharm Sci. 2004; 93: 1337-1350. (Pubitemid 38529706)
96. van As A, Bronsky E, Grossman J, Meltzer EO, Ratner P, Reed C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy. 1991; 67: 156-162.
97. van den Stolpe A, Caldenhoven E, Raaijmakers JAM et al. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol. 1993; 8: 340-347.
98. Wang JH, Davalia JL, Xia C et al. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Biol. 1996; 14: 27-35. (Pubitemid 126443087)
99. Weido AJ, Reece LM, Alam R et al. Intranasal fluticasone proprionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol. 1996; 77: 407-415. (Pubitemid 26422079)
100. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998; 317: 1624-1629. (Pubitemid 28554544)
101. Welch MJ, Bronsky EA, Grossman J, Shapiro GG, Tinkelman DG, Garcia JD, Gillen MS. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy. 1991; 67: 493-498.
102. Welsh PW, Stricker WE, Chu CP, Naessens JM, Reese ME, Reed CE, Marcoux JP. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc. 1987; 62: 125-134.
103. Whelan CFA. Problems in the examination of nasal smears in allergic rhinitis. J Laryngol Otol. 1980; 84: 399-405.
104. Würthwein G, Rehder S, Rohdewald P. Lipophilicity and receptor affinity of glucocorticoids. Pharm Ztg Wiss. 1992; 4: 161-167.